Investors


INVESTOR INFORMATION

SpineGuard Co-Founders

Dear shareholders,

On behalf of the entire SpineGuard team, we warmly thank all of you who supported us since the foundation of the company in 2009, at the IPO on Alternext Euronext Paris in spring 2013 or since then. We are using these proceeds to support the implementation of our growth strategy towards break-even with the following three priorities:

  • Reinforce our primary commercial focus on the US market and support other geographies with strong potential for sales of the DSG™ technology;
  • Support Business Development activities to sign new partnerships with the spine industry for co-developing other DSG™ Smart Screws;
  • Broaden our proprietary technology offerings to new applications and functions (combination with surgical robots, bone quality measurement, entry point determination) as well as new surgical fields beyond spine (joint reconstruction, trauma, maxillo facial or dental).

Since 2009, with the successive launch of PediGuard® Curved, PediGuard Cannulated, PediGuard XS, PediGuard Threaded and most recently the first surgeries performed with our DSG™ integration module for ‘single-step’ screw insertion, we have built a complete range of smart drilling single use devices for securing pedicle screw placement in all spine segments (lumbar, thoracic and cervical), for various indications (degenerative, trauma, tumors and deformities) via open or minimally invasive surgery. 10 papers have already been published in peer reviewed scientific journals backing our DSG™ technology with compelling clinical evidence. Our products are now regulatory approved across the globe, in Europe, the USA, Japan, China, Russia, Brazil, Mexico, etc.

On a commercial standpoint, our network of agents and distributors has become stronger and broader over time allowing us to deliver sustained double-digit growth, drive significant market penetration across the globe in particular in teaching institutions with now a third of US and half of French university hospitals having adopted our DSG™ technology. In total over 55,000 surgeries have been performed with our DSG™ technology since its introduction.

In conclusion, we would like to assure you that SpineGuard team is resolutely focused on accelerating the adoption of our smart drilling devices for spine fusion and the development of innovations derived from our proprietary DSG™ platform. We are proud to contributing to make spine surgery safer every day and remain determined to establish our DSG™ technology as a standard of care in spine surgery and beyond and we would like to thank you again for your continuous support.